ASLN — ASLAN PHARMACEUTICALS LT ADR
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 1 SEC-registered investment managers reported holding ASLN (ASLAN PHARMACEUTICALS LT ADR) in their latest 13F filings, with a combined reported value of $17 across 29 shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved +0.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Major shareholders of ASLAN PHARMACEUTICALS LT ADR (ASLN) include TANG CAPITAL MANAGEMENT LLC, Vivo Capital, LLC, BVF INC/IL, ranked by reported 13F value among the 35 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 1 | 29 | $17 | +0.0% |
| Q2 2026 | 1 | 29 | $17 | +0.0% |
| Q1 2026 | 1 | 29 | $17 | +0.0% |
| Q4 2025 | 1 | 29 | $17 | +0.0% |
| Q3 2025 | 1 | 29 | $17 | -71.3% |
| Q2 2025 | 1 | 101 | $60 | -36.9% |
| Q1 2025 | 1 | 160 | $95 | +0.0% |
| Q4 2024 | 1 | 160 | $95 | +0.0% |
Over the 8 quarters shown, institutional share counts decreased 82% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q3 2025 (-71.3%).
Top Institutional Holders (Q3 2026) — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 29 | $17 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 29 | $17 | 0.00% | Hold |
Q1 2026 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 29 | $17 | 0.00% | Hold |
Q4 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 29 | $17 | 0.00% | Hold |
Q3 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 29 | $17 | 0.00% | Reduce |
Q2 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 101 | $60 | 0.00% | Reduce |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | 29 | 29 | 29 | 29 | 29 | 101 | 160 | 160 | 160 | 1.29K | 1.29K | 1.29K | 1.29K | — | — | — | — | — | — | — |
| TANG CAPITAL MANAGEMENT LLC | — | — | — | — | — | — | — | — | — | — | — | — | 1.90M | — | — | — | — | — | — | — |
| BVF INC/IL | — | — | — | — | — | — | — | — | — | 1.05M | 1.05M | 1.05M | 1.05M | — | — | — | — | — | — | — |
| Velan Capital Investment Management LP | — | — | — | — | — | — | — | — | — | 625.00K | 625.00K | — | 625.00K | — | — | — | — | — | — | — |
| Vivo Capital, LLC | — | — | — | — | — | — | — | — | — | — | — | — | 568.18K | — | — | — | — | — | — | — |
| Parkman Healthcare Partners LLC | — | — | — | — | — | — | — | — | — | — | — | 110.66K | 372.74K | — | — | — | — | — | — | — |
| Temasek Holdings (Private) Ltd | — | — | — | — | — | — | — | — | — | — | — | 15.68K | 335.62K | — | — | — | — | — | — | — |
| Sio Capital Management, LLC | — | — | — | — | — | — | — | — | — | 254.15K | 254.15K | 254.15K | 254.15K | — | — | — | — | — | — | — |
| UBS Group AG | — | — | — | — | — | — | — | — | — | 16.44K | — | 625.00K | — | 100 | — | 2.22K | 1.60K | — | 6.37K | — |
| Shay Capital LLC | — | — | — | — | — | — | — | — | — | 400.00K | 400.00K | 400.00K | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | — | 138.86K | 122.50K | 172.80K | 33.46K | 28.76K | 41.00K | 262.51K | 365.80K | 475.90K | 70.60K | — |
| Schonfeld Strategic Advisors LLC | — | — | — | — | — | — | — | — | — | 124.30K | 147.40K | 27.70K | 91.50K | — | — | — | — | — | — | — |
| MILLENNIUM MANAGEMENT LLC | — | — | — | — | — | — | — | — | — | 46.37K | 39.64K | 80.36K | 80.46K | — | — | — | — | — | — | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | 58.00K | 58.00K | 58.00K | 290.00K | — | — | — | — |
| Waterfront Wealth Inc. | — | — | — | — | — | — | — | — | — | 22.72K | 20.72K | 40.94K | 49.44K | — | — | — | — | — | — | — |
| Morgan Stanley | — | — | — | — | — | — | — | — | — | 8.70K | 8.70K | 24.70K | 28.96K | 28.96K | 30.16K | 150.79K | 150.98K | 254.95K | 496.97K | 250.82K |
| Marex Group Ltd | — | — | — | — | — | — | — | — | — | 83.46K | 83.36K | — | — | — | — | — | — | — | — | — |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | — | — | — | — | — | — | — | — | — | — | — | 83.26K | — | — | — | — | — | — | — | — |
| ADAR1 Capital Management, LLC | — | — | — | — | — | — | — | — | — | — | 59.39K | — | — | — | — | — | — | — | — | — |
| FNY Investment Advisers, LLC | — | — | — | — | — | — | — | — | — | — | 46.70K | — | — | — | — | — | — | — | — | — |
FAQ
Which funds hold ASLN?
As of 2026-Q2, 1 institutional funds reported holding ASLN (ASLAN PHARMACEUTICALS LT ADR) in SEC 13F filings, with a combined reported value of $17.
How many shares of ASLN do institutions own?
13F filers reported 29 shares of ASLN, worth $17 in aggregate at the end of 2026-Q2.
Is institutional ownership of ASLN rising or falling?
Share counts moved +0.0% versus the prior quarter — accumulation.
Who are the top institutional holders of ASLN?
The largest 13F holders are TANG CAPITAL MANAGEMENT LLC, Vivo Capital, LLC, BVF INC/IL, Velan Capital Investment Management LP, Shay Capital LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ASLAN PHARMACEUTICALS LT ADR?
The major shareholders of ASLAN PHARMACEUTICALS LT ADR (ASLN) by reported 13F value are TANG CAPITAL MANAGEMENT LLC, Vivo Capital, LLC, BVF INC/IL, Velan Capital Investment Management LP, Shay Capital LLC, among 35 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.